3 ms·
Except the drug "schrekli" priced gouged was out of patent. It should have been a commodity, so why weren't any competitors allowed on the marketplace? Take a l
by jostmey 10y ago
Except the drug "schrekli" priced gouged was out of patent. It should have been a commodity, so why weren't any competitors allowed on the marketplace? Take a look at Washington for your answer.
There are lots of amazing companies trying to invent cures that don't otherwise exist, and need compensation for their work. Then you have Epipen and "schrekli" jacking up prices on 30 year old drugs.
- kefka 10y agoIndeed. Whatever his name is, used the fact that the FDA has to "authorize" a drug, which is more akin to an indefinite patent. Then again, the deeper we dig, the more idiocy we see. How can we expect anyone to fix: insurance, pharmaceutical, device companies, FDA, AMA, government interference, medical schools - everyone has a part in the current system. And it is the combination of the worst that capitalism and socialism have to offer. And yes, I misspelled his name, because a google search was too much work to get his name correct (marque of disregard). But admittedly, probably was not the best case to explain.